Frontline Therapy Setting
Dixie-Lee Esseltine, MD, George Mulligan, PhD
Video Categories: PMO Interview with the Innovator Series: Volume 10
The publishers of Personalized Medicine in Oncology (PMO) invite you to watch an interview with Peter Hirth, PhD, Chief Executive Officer of Plexxikon. In part one, Dr. Hirth discusses the use of biomarkers, segmenting the population of melanoma patients into subsets, and other aspects of personalized medicine.
John Hennessy provides a few benefits of personalized medicine as it effects the ability to make better treatment choices earlier rather than later